Alsugair A, Fathima S, Aperna F, Gangat N, Tefferi A. Sodium-glucose co-transporter-2 inhibitor treatmentassociated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. haematol [Internet]. 2025Jun.1 [cited 2025Dec.6];110(6):1422-5. Available from: https://haematologica.org/article/view/11914